Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Yuko Hosoe, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi. J Clin Oncol 2015
Times Cited: 675
Times Cited: 675
Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Alexander Reuss, Andres Poveda, Gunnar Kristensen, Roberto Sorio, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias, Deolinda Pereira, Pauline Wimberger, Ana Oaknin, Mansoor Raza Mirza, Philippe Follana, David Bollag, Isabelle Ray-Coquard. J Clin Oncol 2014
Times Cited: 844
Times Cited: 844
List of shared articles
Times cited
Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer.
Hiroki Nasu, Shin Nishio, Jongmyung Park, Teruyuki Yoshimitsu, Ken Matsukuma, Kazuto Tasaki, Takahiro Katsuda, Atsumu Terada, Naotake Tsuda, Kimio Ushijima. Int J Clin Oncol 2022
Hiroki Nasu, Shin Nishio, Jongmyung Park, Teruyuki Yoshimitsu, Ken Matsukuma, Kazuto Tasaki, Takahiro Katsuda, Atsumu Terada, Naotake Tsuda, Kimio Ushijima. Int J Clin Oncol 2022
Therapeutic strategies to overcome cisplatin resistance in ovarian cancer.
Mengdi Song, Mingxiao Cui, Kehai Liu. Eur J Med Chem 2022
Mengdi Song, Mingxiao Cui, Kehai Liu. Eur J Med Chem 2022
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment.
Esther Schoutrop, Lidia Moyano-Galceran, Stephanie Lheureux, Jonas Mattsson, Kaisa Lehti, Hanna Dahlstrand, Isabelle Magalhaes. Semin Cancer Biol 2022
Esther Schoutrop, Lidia Moyano-Galceran, Stephanie Lheureux, Jonas Mattsson, Kaisa Lehti, Hanna Dahlstrand, Isabelle Magalhaes. Semin Cancer Biol 2022
Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy.
Chengwen Jin, Mingyuan Yuan, Hualei Bu, Chengjuan Jin. J Oncol 2022
Chengwen Jin, Mingyuan Yuan, Hualei Bu, Chengjuan Jin. J Oncol 2022
The role of vascular endothelial growth factor inhibitors in the treatment of epithelial ovarian cancer.
Alexander D Murphy, Robert D Morgan, Andrew R Clamp, Gordon C Jayson. Br J Cancer 2022
Alexander D Murphy, Robert D Morgan, Andrew R Clamp, Gordon C Jayson. Br J Cancer 2022
Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket study.
Lingfang Xia, Jin Peng, Ge Lou, Mei Pan, Qi Zhou, Wenjing Hu, Huirong Shi, Li Wang, Yunong Gao, Jianqing Zhu,[...]. J Immunother Cancer 2022
Lingfang Xia, Jin Peng, Ge Lou, Mei Pan, Qi Zhou, Wenjing Hu, Huirong Shi, Li Wang, Yunong Gao, Jianqing Zhu,[...]. J Immunother Cancer 2022
Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities.
Sepideh Azarianpour, Germán Corredor, Kaustav Bera, Patrick Leo, Pingfu Fu, Paula Toro, Amy Joehlin-Price, Mojgan Mokhtari, Haider Mahdi, Anant Madabhushi. J Immunother Cancer 2022
Sepideh Azarianpour, Germán Corredor, Kaustav Bera, Patrick Leo, Pingfu Fu, Paula Toro, Amy Joehlin-Price, Mojgan Mokhtari, Haider Mahdi, Anant Madabhushi. J Immunother Cancer 2022
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial.
Jung-Yun Lee, Byoung-Gie Kim, Jae-Weon Kim, Jung Bok Lee, Eunhyang Park, Je-Gun Joung, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim. J Gynecol Oncol 2022
Jung-Yun Lee, Byoung-Gie Kim, Jae-Weon Kim, Jung Bok Lee, Eunhyang Park, Je-Gun Joung, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim. J Gynecol Oncol 2022
Current status of cancer immunotherapy for gynecologic malignancies.
Hiroshi Nishio, Takashi Iwata, Daisuke Aoki. Jpn J Clin Oncol 2021
Hiroshi Nishio, Takashi Iwata, Daisuke Aoki. Jpn J Clin Oncol 2021
Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease.
Rebecca C Arend, Amy Jackson-Fisher, Ira A Jacobs, Jeffrey Chou, Bradley J Monk. Cancer Biol Ther 2021
Rebecca C Arend, Amy Jackson-Fisher, Ira A Jacobs, Jeffrey Chou, Bradley J Monk. Cancer Biol Ther 2021
Programmed death ligand-1 regulates angiogenesis and metastasis by participating in the c-JUN/VEGFR2 signaling axis in ovarian cancer.
Yufei Yang, Lingfang Xia, Yong Wu, Hongyu Zhou, Xin Chen, Haoran Li, Midie Xu, Zihao Qi, Ziliang Wang, Huizhen Sun,[...]. Cancer Commun (Lond) 2021
Yufei Yang, Lingfang Xia, Yong Wu, Hongyu Zhou, Xin Chen, Haoran Li, Midie Xu, Zihao Qi, Ziliang Wang, Huizhen Sun,[...]. Cancer Commun (Lond) 2021
Advances in the treatment of platinum resistant epithelial ovarian cancer: an update on standard and experimental therapies.
Shuk On Annie Leung, Panagiotis A Konstantinopoulos. Expert Opin Investig Drugs 2021
Shuk On Annie Leung, Panagiotis A Konstantinopoulos. Expert Opin Investig Drugs 2021
CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer.
Mayu Shiomi, Shinya Matsuzaki, Satoshi Serada, Koji Matsuo, Chihiro Mizuta-Odani, Mariko Jitsumori, Ruriko Nakae, Satoko Matsuzaki, Satoshi Nakagawa, Kosuke Hiramatsu,[...]. Cancer Sci 2021
Mayu Shiomi, Shinya Matsuzaki, Satoshi Serada, Koji Matsuo, Chihiro Mizuta-Odani, Mariko Jitsumori, Ruriko Nakae, Satoko Matsuzaki, Satoshi Nakagawa, Kosuke Hiramatsu,[...]. Cancer Sci 2021
SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors.
Alba Gonzalez-Junca, Frances D Liu, Archana S Nagaraja, Alyssa Mullenix, Chen-Ting Lee, Russell M Gordley, Daniel O Frimannsson, Ori Maller, Brian S Garrison, Dharini Iyer,[...]. Mol Cancer Ther 2021
Alba Gonzalez-Junca, Frances D Liu, Archana S Nagaraja, Alyssa Mullenix, Chen-Ting Lee, Russell M Gordley, Daniel O Frimannsson, Ori Maller, Brian S Garrison, Dharini Iyer,[...]. Mol Cancer Ther 2021